The objective was to give an
overview of self-reported recreational drug use amongst attendees of sexual
health clinics in London and compare this to existing datasets. Between
December 2013 and March 2014, attendees of two sexual health clinics in London
were surveyed. Data collected were: sexual history, smoking and alcohol and
recreational drug use.
Data were analysed using SPSS (version 21). A total of
1472 respondents were included; 778 (52.9%) men, 676 (45.9%) women and 3 (0.2%)
transgender (15 [1.0%] did not answer). Mean age was 30.6 ± 9.0 years. A total
of 339 (43.6%) men were men who have sex with men, and 18 (2.4%) women were
women who have sex with women.
Lifetime prevalence of use was: alcohol 94.1%;
cannabis 48.5%; 'poppers' (volatile nitrites) 28.2%; cocaine 26.8% and
3,4-methylenedioxy-methamphetamine pills 23.2%. Our population had higher
current popper, methamphetamine and mephedrone use than the Crime Survey of
England and Wales but lower use of cannabis, poppers and Viagra than the
European MSM Internet Survey.
Global Drug Survey and Part of the Picture
respondents' use were higher than our population for all drugs. Drug use in
this population had a different pattern to general population surveys and
studies involving only men who have sex with men.
Purchase full article at: http://goo.gl/AB736V
- 1Clinical Toxicology Department, Guys and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK nat_thurtle@yahoo.com.
- 2Clinical Toxicology Department, Guys and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK Clinical Toxicology Department, King's College London, London, UK.
- 3Clinical Toxicology Department, Guys and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
- 4Genitourinary Medicine, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment